Where is Biocore located?

Biocore is headquartered in Charlottesville, United States.

How many employees does Biocore have?

As of Sep 30, 2026, the latest employee count at Biocore is 50.

Where does Biocore rank among its competitors?

Biocore ranks 56th amongst 1110 active competitors, of which 71 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Caidya, which secured $165M in Jan, 2025.

Who are the top competitors of Biocore?

Biocore's top competitors include WuXi AppTec, Precision Medicine Group and ANI Pharmaceuticals. Among them, Caidya secured the most recent funding round in January, 2025.

Biocore - 2026 Company Profile, Team & Competitors

Company Details

Website: biocorellc.com
Email ID: *****@biocorellc.com
Phone Number: +1 **********

Key Metrics

Founded Year

1991

Location

Charlottesville, United States

Stage

Acquired

Ranked

56^th among 1110 active competitors

Employee Count

50 as on Sep 30, 2026

Similar Companies

WuXi AppTec & 1154 more

Exit Details

Acquired by Infinite Athlete (Aug 04, 2023)

View Biocore's full profile

Biocore got acquired by Infinite Athlete on Aug 04, 2023.

Click here to take a look at Biocore's acquisition in detail

Biocore has not raised any funding rounds yet.

Biocore's employee count trend

Biocore has 50 employees as of Sep 26. Here is Biocore's employee count trend over the years:

Uncover Biocore's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biocore include WuXi AppTec, Precision Medicine Group and ANI Pharmaceuticals. Here is the list of Top 10 competitors of Biocore, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	WuXi AppTec 2000, Shanghai (China), Public	Provider of CRO and CDMO services	$40M	Synergis Capital, HongShan & 27 others	75/100
2nd	Precision Medicine Group 2012, Bethesda (United States), Late Stage	Provider of clinical research, development, and commercialization services for life sciences	$532M	TPG, Oak Investment Partners & 7 others	72/100
3rd	ANI Pharmaceuticals 1996, Baudette (United States), Public	Manufacturer of pharmaceutical products, including extended-release capsules and immediate-release tablets	-	JPMorgan Chase, Ampersand Capital & 4 others	64/100
4th	Ipsen 1929, Paris (France), Public	Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes	-	Digital Pharma Lab, PAI Partners & 2 others	63/100
5th	Zuellig Pharma 1992, Singapore (Singapore), Funding Raised	Provider of clinical research, quality management, logistics, and clinical trial supply services	-	Temasek	61/100
6th	Eurofins Scientific 1987, Luxembourg (Luxembourg), Public	Provider of laboratory testing services and CRO contract research services	-	CDPQ, Holland Capital & 1 others	61/100
7th	EVERSANA 2014, Milwaukee (United States), Funding Raised	Provider of consulting services for drug pricing access, reimbursement, and regulatory support	-	North Sky Capital, Pantheon International ... & 3 others	57/100
8th	China Medical System 1992, Shenzhen (China), Public	Manufacturer of generic formulations	-	CMS Ventures	55/100
9th	Caidya 2003, Morrisville (United States), Series C	CRO focused on clinical development for phases II & III clinical trials and regulatory affair services	$373M	Qiming Venture Partners, Fidelity Investments ... & 22 others	54/100
10th	Red Nucleus 2014, Yardley (United States), Acquired	Provider of advisory, scientific and medical communications for pharmaceutical industry	-	Maranon Capital, Renovus Capital Partners	52/100
56th	Biocore 1991, Charlottesville (United States), Acquired	Provider of testing, analysis, and other consulting services	-	-	40/100